This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA
Book Now
Menu
Book

Dr. Rachel Johns, PhD
Executive Director, Analytical Development, Formulations, QC at Avidity Biosciences
Speaker

Agenda Sessions

  • Manufacturing and Controls to Enable Clinical and Commercial use of Antibody Oligonucleotide Conjugates

    , 10:45am
    View Session

At this event

Prev
Next
Aimee Jackson, PhD
Founder
Jackson Bioscience Consulting

See Rachel at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now